iZafe Group AB
STO:IZAFE B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
iZafe Group AB
Total Receivables
iZafe Group AB
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
i
|
iZafe Group AB
STO:IZAFE B
|
Total Receivables
kr2.5m
|
CAGR 3-Years
31%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
51%
|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Total Receivables
kr541.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Total Receivables
kr29.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
M
|
Mentice AB
STO:MNTC
|
Total Receivables
kr69.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Total Receivables
kr10.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Total Receivables
kr719.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
iZafe Group AB
Glance View
iZafe Group AB is a medical technology company, which engages in the research, development, and marketing of medical and digital security solutions. The company is headquartered in Stockholm, Stockholm and currently employs 11 full-time employees. The company went IPO on 2011-04-04. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The firm operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. The company is active globally.
See Also
What is iZafe Group AB's Total Receivables?
Total Receivables
2.5m
SEK
Based on the financial report for Dec 31, 2025, iZafe Group AB's Total Receivables amounts to 2.5m SEK.
What is iZafe Group AB's Total Receivables growth rate?
Total Receivables CAGR 10Y
51%
Over the last year, the Total Receivables growth was 133%. The average annual Total Receivables growth rates for iZafe Group AB have been 31% over the past three years , -15% over the past five years , and 51% over the past ten years .
